Research Associates



Agnese Po,PhD


Postdoc since 2009 and PhD at Sapienza University in 2008, working on “Brain stem cells: hedgehog and notch pathways in brain stem cells”, with the goal to characterize cell signaling in mouse and human neuronal stem cells and to investigate their aberration in CNS tumors.




Agnese Po -


Francesca Bufalieri, PhD in Molecular Medicine


Research in the role of post translation modification in Hedgehog-related tumorigenesis.





Francesca Bufalieri -


Giuseppina Catanzaro, PhD


Research activity in the field of pediatric molecular oncology with particular interest in the analysis of Sonic Hedgehog signaling pathways activation in high grade and low grade pediatric brain tumors.




Giuseppina Catanzaro -


Laura Di Magno, PhD


AMPK is a master regulator of cellular bioenergetics that links oncogenic signaling to tumor metabolism. Characterizing the metabolic phenotype and understanding its interplay with oncogenic pathways to fuel brain tumors growth is the main focus of my research. Drugs traditionally used to treat metabolic diseases are evaluated for their ability toinduce metabolic stress and inhibit brain tumorigenesis.



Laura Di Magno -


Marialaura Petroni, PhD


PhD in Molecular Medicine (2009) and resident Postdoc since 2011, working on interactions between MYCN and the DNA damage response patway in neuronal development and carcinogenesis: "role of MRN complex in regulating MYCN dependent proliferation and transformation".




Marialaura Petroni -


Marta Moretti, PhD


Molecular bases of diseases: Stem cells in development and pathology Hedgehog signalling in neural development and pathology.





Marta Moretti -


Sonia Coni, PhD


Post-doc since 2010, working on the transcriptional and epigenetic regulation of Hedgehog-dependent cell growth in mammals. After a period abroad (2011 - 2013), at the CNRS (France) in which she studied the molecular mechanism of Hedgehog-dependent development in Drosophila Melanogaster, she is now focusing her studies on the identification of new pharmacological targets in developmental pathways, which could have a key role in cancer cell growth.



Sonia Coni -